Clinical Trial Update: COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for the COVID-19 vaccine ChAdOx1 nCoV-19 in South African adults with and without HIV (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus

Drugs mentioned

• ChAdOx1 nCoV-19

Snippet

Sponsor: University of Oxford | Conditions: Coronavirus | Phase 1, Phase 2 | Status: UNKNOWN